Collaboration aims to develop new medicines for neurodegenerative diseases

Focused chemists in lab coats and safety goggles making experiments.

The ALBORADA Drug Discovery Institute (ADDI) today (Tuesday 8 November) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.

Pay what you want for this stacked collection of photography assets

Previous article

Zoom is coming to Tesla so you can Zoom in your Tesla

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News